Ear Wax Build-Up
NDC 55714-2428, Elaps corallinus, Alumina, Carbo veg., Causticum, Conium, Graphites, Kali bic.,Kali mur., Lachesis, Lycopodium, Petroleum, Pulsatilla, Sabadilla, Sepia, Silicea, Spongia, Verbascum, Viola odorata, liquid, from Newton Laboratories, Inc..
- Product NDC
- 55714-2428
- Status
- Listed
- Labeler
- Newton Laboratories, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55714-2428 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MICRURUS CORALLINUS VENOM30 [hp_X]/mL
- ALUMINUM OXIDE15 [hp_X]/mL
- ACTIVATED CHARCOAL15 [hp_X]/mL
- CAUSTICUM15 [hp_X]/mL
- CONIUM MACULATUM FLOWERING TOP15 [hp_X]/mL
- GRAPHITE15 [hp_X]/mL
- POTASSIUM DICHROMATE15 [hp_X]/mL
- POTASSIUM CHLORIDE15 [hp_X]/mL
- LACHESIS MUTA VENOM15 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE15 [hp_X]/mL
- LIQUID PETROLEUM15 [hp_X]/mL
- PULSATILLA VULGARIS15 [hp_X]/mL
- SCHOENOCAULON OFFICINALE SEED15 [hp_X]/mL
- SEPIA OFFICINALIS JUICE15 [hp_X]/mL
- SILICON DIOXIDE15 [hp_X]/mL
- SPONGIA OFFICINALIS SKELETON, ROASTED15 [hp_X]/mL
- VERBASCUM THAPSUS15 [hp_X]/mL
- VIOLA ODORATA15 [hp_X]/mL
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55714-2428-1 | 55714242801 | 30 mL in 1 BOTTLE, GLASS (55714-2428-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 55714-2428 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55714-2428 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55714-2428. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.